Skip to content

The development and pilot randomized controlled trial of behavioral activation program for adolescents

The development and pilot randomized controlled trial of behavioral activation program for adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011835
Enrollment
54
Registered
2026-04-13
Start date
2021-08-02
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : The interventions in this study consisted of internet-based Behavioral Activation treatment (iBA) and internet-based psychoeducation and supportive treatment (iST). In both groups, adoles

Sponsors

Korea University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Eligibility criteria were as follows: (1) adolescents currently attending middle or high school (aged 12-19 years) who provided assent to participate and whose participation was approved by one parent or legal guardian; (2) adolescents who met DSM-5 (APA, 2013) criteria for a primary diagnosis of a depressive disorder based on the K-SADS-PL (Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version); and (3) adolescents who agreed to random assignment to the treatment conditions.

Exclusion criteria

Exclusion criteria: The exclusion criteria were as follows: (1) current or past diagnostic criteria for bipolar disorder or a schizophrenia spectrum disorder; (2) current intellectual disability or autism spectrum disorder; (3) current conduct disorder, life-threatening anorexia nervosa, or obsessive-compulsive disorder requiring prioritized treatment; (4) meeting diagnostic criteria for a substance use disorder within the past 3 months, excluding nicotine and caffeine use disorders; (5) suicide risk requiring immediate and intensive intervention (e.g., hospitalization); (6) the presence of other medical conditions that would make participation in the study difficult; and (7) current participation in other individual or group psychotherapy. Exclusion criteria (1) through (4) were applied in cases where the participant’s symptoms were better explained by a disorder other than depressive disorder and where separate treatment primarily targeting that condition was considered necessary. Participants who met the inclusion criteria but were taking medication for depressive or anxiety symptoms were allowed to participate if their dosage had been stable for at least 4 weeks prior to the baseline assessment.

Design outcomes

Primary

MeasureTime frame
Change in clinician-rated depressive symptoms measured by the Children’s Depression Rating Scale-Revised;Change in self-reported depressive symptoms measured by the Korean Children’s Depression Inventory, 2nd Edition

Secondary

MeasureTime frame
Change in behavioral activation level measured by the Behavioral Activation for Depression Scale (BADS);Change in response-contingent positive reinforcement measured by the Reward Probability Index (RPI);Change in negative automatic thoughts measured by the Automatic Thoughts Questionnaire (ATQ);Change in overall functioning measured by the Children’s Global Assessment Scale (CGAS)

Countries

Korea, Republic of

Contacts

Public ContactEunbyeol Lee

Korea University

yinxing0222@gmail.com+82-2-3290-2867

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Apr 23, 2026